SEC
Filing

SEC Filing Details

Document Details

Form
Filing Date
Feb 14, 2022
Document Date
Dec 31, 2021
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Altimmune
Issuer
ALTIMMUNE, INC.
Filer
GILL JOHN
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe